NK 250 potentiates the action of antitumor drugs against drug-sensitive tumors. References: Kiue A, Sano T, Naito A, Inada H, Suzuki K, Okumura M, Kikuchi J, Sato S, Takano H, Kohno K, et al. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro. Jpn J Cancer Res. 1990 Oct;81(10):1057-64. PubMed PMID: 1977728; PubMed Central PMCID: PMC5917977.

纯度：≥98%

CAS：126444-09-5